The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients

Status Recruiting

Clinical Trial Summary

The (World Health Organization) WHO NOR- (Coronavirus infectious disease) COVID 19 study is a multi-centre, adaptive, randomized, open clinical trial to evaluate the safety and efficacy of hydroxychloroquine, remdesivir and standard of care in hospitalized adult patients diagnosed with COVID-19. This trial will follow the core WHO protocol but has additional efficacy, safety and explorative endpoints.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Acute Lung Injury
Acute Respiratory Distress Syndrome ARDS
Coronavirus Infections
COVID 19
Respiratory Distress Syndrome, Adult
Respiratory Distress Syndrome, Newborn
SARS-CoV Infection
Severe Acute Respiratory Syndrome

Clinical Trial Details

NCT number	NCT04321616
Study type	Interventional
Source	Oslo University Hospital
Contact	Paul Aukrust, MD, Professor
Phone	0047 46778374
Email	paukrust@ous-hf.no
Status	Recruiting
Phase	Phase 2/Phase 3
Start date	March 28, 2020
Completion date	November 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04961541` - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine	Phase 1/Phase 2
Active, not recruiting	`NCT04546776` - COVID-19 Persistence in Stool
Terminated	`NCT04542993` - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy	Phase 2
Completed	`NCT04542915` - COVID-19-Related Health and Practices Among Dental Hygienists
Completed	`NCT05065827` - Lung Ultrasound Findings in Patients With COVID-19 in a UK ED
Recruiting	`NCT04615052` - Home-based Exercise in COVID-19 Survivors	N/A
Enrolling by invitation	`NCT04659486` - Adolescents With COVID-19/MIS-C at HCFMUSP	N/A
Recruiting	`NCT04885452` - Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.
Completed	`NCT04516928` - Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel
Completed	`NCT05063812` - Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19
Completed	`NCT04530357` - Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine	Phase 1/Phase 2
Recruiting	`NCT04565782` - Corona Virus Infection Among Liver Transplant Recipients
Completed	`NCT04733625` - The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection	N/A
Completed	`NCT04550390` - Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19
Active, not recruiting	`NCT04517136` - Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions
Recruiting	`NCT04476680` - Influence of Military Preventive Policy for reCruit Training on COVID-19 Seroconversion	N/A
Completed	`NCT04839913` - Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study
Completed	`NCT04514874` - Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020
Terminated	`NCT04606563` - Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?	Phase 3
Completed	`NCT05234359` - The CHILD Cohort COVID-19 Add-On Study